AngioDynamics (ANGO) vs Bausch + Lomb (BLCO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
AngioDynamics (ANGO) has outperformed Bausch + Lomb (BLCO) over the past year, gaining 28.4% versus a gain of 18.3%. Bausch + Lomb is the larger company by market cap ($6.13 billion vs $472.3 million), about 13.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANGO | BLCO |
|---|---|---|
| Share price | $11.23 | $17.15 |
| Market cap | $472.27M | $6.13B |
| 1-day change | -20.86% | -1.10% |
| YTD return | +10.51% | +1.52% |
| 1-year return | +28.42% | +18.28% |
| 5-year return | -48.15% | — |
| Forward P/E | — | 15.40 |
| EPS (TTM) | $-0.88 | $-0.49 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $5.10B |
| Revenue growth (YoY) | — | +6.47% |
| Net income (latest FY) | — | $-360.00M |
| Operating margin | — | 2.22% |
| Net margin | — | -7.06% |
| 52-week high | $16.29 | $18.92 |
| 52-week low | $9.39 | $13.77 |
| Distance from 52-week high | -31.06% | -9.33% |
| Analyst consensus | none | buy |
| Avg. price target upside | +78.09% | +13.06% |
| Average volume | 514.11K | 392.13K |
| Shares outstanding | 42.05M | 357.17M |
| Employees | 632 | 13,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bausch + Lomb is about 13.0 times larger than AngioDynamics by market value ($6.13B vs $472.27M).
- ANGO has outperformed BLCO by 10.1 percentage points over the past year.
About AngioDynamics
ANGO stock →AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments.
Health Care · Medical/Dental Instruments · 632 employees
About Bausch + Lomb
BLCO stock →Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical.
Health Care · Ophthalmic Goods · 13,000 employees
ANGO vs BLCO FAQ
Which is bigger, AngioDynamics or Bausch + Lomb?
Bausch + Lomb (BLCO) is larger, with a market capitalization of $6.13B compared with $472.27M for AngioDynamics (ANGO).
Which stock has performed better over the past year, ANGO or BLCO?
ANGO returned +28.42% over the past 12 months, compared with +18.28% for BLCO (price return, excluding dividends). Past performance does not predict future results.
Are AngioDynamics and Bausch + Lomb in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for AngioDynamics and Ophthalmic Goods for Bausch + Lomb.